Short-Chain Acyl-CoA Dehydrogenase Deficiency Associated with Early Onset Severe Axonal Neuropathy

Abstract

Two unusual cases of axonal neuropathy associated with short-chain acyl-CoA dehydrogenase (SCAD) deficiency are described. These two unrelated infants presented with profound generalised weakness, particularly affecting the upper limbs. Clinical examination revealed generalised peripheral hypotonia and weakness, with absent deep tendon reflexes. An axonal polyneuropathy was confirmed on electromyogram (EMG) and nerve conduction studies (NCS) and, following an extensive metabolic screen, an acylcarnitine and organic acid profile consistent with a short-chain fatty acid beta-oxidation defect was found. In both cases, SCAD deficiency was confirmed by enzyme analysis. Genetic analysis showed the presence of common gene variations in the SCAD gene. SCAD deficiency is a rare disorder with a wide clinical phenotype. SCAD deficiency associated with axonal neuropathy has not previously been reported. As highlighted in these cases, it may be necessary to include axonal neuropathy as a presenting feature of SCAD.

Key words

Axonal neuropathy - fatty acid oxidation defect - SCAD

References

• 1 Bertini E, Dionisi-Vici C, Garavaglia B, Burlina A B, Sabatelli M, Rimoldi. et al . Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency.  Eur J Paediatr. 1992;  151 121-126
• 2 Bhala A, Willi S M, Rinaldo P, Bennett M J, Schmidt-Sommerfeld E, Hale D E. Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency.  J Pediatr. 1995;  126 910-915
• 3 Birkebaek N H, Simonsen H, Gregersen N. Hypoglycaemia and elevated urinary ethylmalonic acid in a child homozygous for the short-chain acyl-CoA dehydrogenase 625 G → A gene variation.  Acta Paediatr. 2002;  91 480-482
• 4 denBoer M E, Dionisi-Vici C, Chakrapani A, van Thuijl A O, Wanders R J, Wijburg F A. Mitochondrial trifunctional protein deficiency: a severe fatty oxidation disorder with cardiac and neurologic involvement.  J Paediatr. 2003;  142 684-689
• 5 Corydon M J, Vockley J, Rinaldo P, Rhead W J, Kjeldsen M, Winter V. et al . Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency.  Pediatr Res. 2001;  49 18-23
• 6 Corydon M J, Andresen B S, Bross P, Kjeldsen M, Andreasen P H, Eiberg H. et al . Structural organisation of the human short-chain acyl-CoA dehydrogenase gene.  Mamm Genome. 1997;  8 922-926
• 7 Gregersen N, Winter V S, Corydon M J, Corydon T J, Rinaldo P, Ribes A. et al . Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511 C → T is present at an unexpectedly high frequency in the general population, as was the case for 625 G → A together conferring susceptibility to ethylmalonic aciduria.  Hum Mol Genet. 1998;  7 619-627
• 8 Ibdah J A, Tein I, Dionisi-Vici C, Bennett M J, IJlst L, Gibson B, Wanders R J, Strauss A W. Mild trifunctional protein deficiency is associated with progressive neuropathy and myopathy and suggests a novel genotype-phenotype correlation.  J Clin Invest. 1998;  102 1193-1199
• 9 Kristensen M J, Bross P, Bhala A, Hale D E, Jensen T G, Gregersen N. New point mutations in short-chain acyl-CoA dehydrogenase.  Am J Hum Genet. 1993;  53 915A
• 10 Kristensen M J, Kmoch S, Bross P, Andersen B S, Gregersen N. Amino acid polymorphism (Gly209Ser) in the ACADS gene.  Hum Mol Genet. 1994;  3 1711
• 11 Leipnitz G, Schuck P F, Ribeiro C A, Dalcin K B, Assis D R, Barschak A G, Pulrolnik V, Wannmacher C M, Wyse A T, Wajner M. Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro.  Neurochem Res. 2003;  5 771-777
• 12 Miller R G, Kuntz N I. Nerve conduction studies in infants and children.  J Child Neurol. 1986;  1 225
• 13 Miyajima H, Orii K E, Shindo Y, Hashimoto T, Shinka T, Kuhara T, Matsumoto I, Shimizu H, Kaneko E. Mitochondrial trifunctional protein deficiency associated with recurrent myoglobinuria in adolescence.  Neurology. 1997;  49 883-887
• 14 Nagan N, Kruckeberg K E, Tauscher A L, Bailey K S, Rinaldo P, Matern D. The frequency of short-chain acyl-CoA dehydrogenase gene variants in the US population and correlation with the C(4)-acylcarnitine concentration in newborn blood spots.  Mol Genet Metab. 2003;  78 239-246
• 15 Naito E, Ozasa H, Ikeda Y, Tanaka K. Molecular cloning and nucleotide sequencing of complementary DNAs encoding human short chain acyl-coenzyme A dehydrogenase and the study of the molecular basis of human short-chain acyl-coenzyme A dehydrogenase deficiency.  J Clin Invest. 1989;  83 1605-1613
• 16 Naito E, Indo Y, Tanak K. Identification of two variant short chain acyl-coenzyme A dehydrogenase alleles, each containing a different point mutation in a patient with short-chain acyl-coenzyme A dehydrogenase deficiency.  J Clin Invest. 1990;  85 1575-1582
• 17 Ribes A, Riudor E. et al . Mild or absent clinical signs in twin sisters with short-chain acyl-CoA dehydrogenase deficiency.  Eur J Paediat Neurol. 1998;  157 317-320
• 18 Roe C R. Diagnostic approach to disorders of fat oxidation.  International Paediatrics. 1996;  109-113
• 19 Saudubray J M, Martin D, de Lonlay P, Touati G, Poggi-Travert F, Bonnet D. et al . Recognition and management of fatty acid oxidation defects: a series of 107 patients.  J Inherit Metab Dis. 1999;  22 488-502
• 20 Sewell A C, Herwig J, Bohles H, Rinaldo P, Bhala A, Hale D E. A new case of short-chain acyl-CoA dehydrogenase deficiency with isolated ethylmalonic aciduria.  Eur J Pediatr. 1993;  152 922-924
• 21 Speikerkoetter U, Bennett M J, Ben-Zeev B, Strauss A W, Tein I. Peripheral neuropathy, episodic myoglobinuria and respiratory failure in deficiency of the mitochondrial trifunctional protein.  Muscle and Nerve. 2004;  29 67-72
• 22 Speikerkoetter U, Sun B, Khuchua Z, Bennett M J, Strauss A W. Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to β-subunit mutations.  Human Mutation. 2003;  21 598-607
• 23 Tein I. Role of Carnitine and fatty acid oxidation and its defects in infantile epilepsy.  J Child Neurol. 2002;  17 (Suppl 3) 3S57-82 3S82-83 (discussion)
• 24 Tein I, Haslam R H, Rhead W J, Bennett M J, Becker L E, Vockley J. Short-chain acyl dehydrogenase deficiency; a cause of ophthalmoplegia and multicore myopathy.  Neurology. 1999;  52 366-372
• 25 Turnbull D M, Bartlett K, Stevens D L, Alberti K GMM, Gibson G J, Johnson M A. et al . Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid storage myopathy and secondary carnitine deficiency.  New Eng J Med. 1984;  311 1232-1236
• 26 Tyni T, Pihko H. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.  Acta Paediatr. 1999;  88 237-245
• 27 Wilmshurst J M, Pollard J D, Nicholson G, Antony J, Ouvrier R. Peripheral neuropathies of infancy.  Dev Med Child Neurol. 2003;  45 408-414